4Life Transfer Factor Transfer Factor and Immune System Transfer Factor Defined

May 21, 2009

New 4Life Research Patent Edges Out the Competition

By innetent

New Patent Edges Out the Competition

Patent Covers Transfer Factor Manufacturing Processes

the U.S. Patent and Trademark Office has issued a new Transfer Factor™ patent to 4Life. The patent, US Patent No. 6,866,868, deals with the special manufacturing processes 4Life uses in preparing synergistic combinations of William Hennen, Chief Scientific Officer at 4Life, commented on the new patent, saying, “The techniques we use allow us to more efficiently and thus more economically manufacture our 4Life Transfer Factor® products. This newly acquired patent gives us a distinct edge in a competitive marketplace.” David Lisonbee, Chief Executive Officer of 4Life, remarked, “The patent recently issued to us further solidifies our position in the market as the world’s leading manufacturer of transfer factor products. We’re pleased to have the protection this patent provides for the unique processing methods we use to manufacture 4Life Transfer Factor products. I’m thankful to our Research and Development team for their dedication and commitment in bringing this patent to fruition.” 4Life is the world’s foremost leader in the development, production and distribution of 4Life Transfer Factor immune support products and was recognized by Inc. magazine as the fifteenth fastest growing privately-held company in America ” target=”_blank”>transfer factors derived from cow colostrum and chicken egg yolks. This new patent specifically applies to all of the 4Life products that contain the Transfer Factor E-XF™ blend.

William Hennen, Chief Scientific Officer at 4Life, commented on the new patent, saying, “The techniques we use allow us to more efficiently and thus more economically manufacture our 4Life Transfer Factor® products. This newly acquired patent gives us a distinct edge in a competitive marketplace.”

QUESTIONS, INQUIRIES OR FEED BACK, CONTACT US

David Lisonbee, Chief Executive Officer of 4Life, remarked, “The patent recently issued to us further solidifies our position in the market as the world’s leading manufacturer of transfer factor products. We’re pleased to have the protection this patent provides for the unique processing methods we use to manufacture 4Life Transfer Factor products. I’m thankful to our Research and Development team for their dedication and commitment in bringing this patent to fruition.”

4Life is the world’s foremost leader in the development, production and distribution of 4Life Transfer Factor immune support products and was recognized by Inc. magazine as the fifteenth fastest growing privately-held company in America

Share/Save/Bookmark

Topics: News and Articles | No Comments »

Comments

You must be logged in to post a comment.

« | Home | »